Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry

Leukemia

Volumn 10, Issue 2, 1996, Pages 197-203

  Arico M ^a   Janka, G ^f   Fischer, A ^b,c   Henter, J I ^d   Blanche, S ^b,c   Elinder, G ^d   Martinetti, M ^a   Rusca, M P ^e  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d KAROLINSKA INSTITUTE   (Sweden)

^e Tavolo di Lavoro AIOM Oncologia Geriatrica   (Italy)

^f IRCCS Policlinico S Matteo ^*

Author keywords

Etoposide; Hemophagocytic; Histiocytosis; HLA; Lymphohistiocytosis; Natural killer

Indexed keywords

EPIPODOPHYLLOTOXIN; ETOPOSIDE; HLA B7 ANTIGEN; HLA B8 ANTIGEN; METHOTREXATE; TENIPOSIDE; VINBLASTINE; VINCRISTINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; CHROMOSOME ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; HEMOPHAGOCYTIC SYNDROME; HISTIOCYTOSIS; HUMAN; INFANT; INFECTION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; ONSET AGE; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REGISTER; REVIEW; SIBLING; SPLENECTOMY; SURVIVAL RATE; TWINS;

EID: 0029879812     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Farquhar J, Claireaux A. Familial haemophagocytic reticulosis. Arch Dis Child 1952; 27: 519-525.
2. Gencik A, Signer E, Muller H. Genetic analysis of familial erythrophagocytic lymphohistiocytosis. Eur J Pediatr 1984; 142: 248-252.
3. Henter JI, Elinder G, Soder O, Ost A. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis, Acta Paediatr Scand 1991; 80: 428-435.
4. Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983; 140: 221-230.
5. Gilbert EF et al. Familial hemophagocytic lymphohistiocytosis: report of four cases in two families and review of the literature. Pediatr Pathol 1985; 3: 59-64.
6. Ladisch S. Lipid abnormalities and immunodeficiency in familial erythrophagocytic lymphohistiocytosis. Pediatr Hematol Oncol 1989; 6: 283-286.
7. Chu T et al. for The Histiocyte Society Writing Group. Histiocytosis syndromes in children. Lancet 1987; i: 208-209.
8. Goldberg JC, Nezelof C. Familial lymphohistiocytosis: the pathologist's view. Pediatr Hematol Oncol 1989; 6: 199-204.
9. Favara B. Histiocytosis syndromes and related disorders of early infancy: a pathologist's perspective. Pediatr Hematol Oncol 1989; 6: 213-216.
10. Ladisch S, Holiman B, Poplack DG, Blaese MR. Immunodeficiency in familial erythrophagocytic lymphohistiocytosis. Lancet 1978; i: 581-583.
11. Perez N et al. Impaired natural killer activity in lymphohistiocytosis syndrome. J Pediatr 1984; 104: 569-573.
12. Aricò M et al. Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis. Arch Dis Child 1988; 63: 292-296.
13. Henter J-I et al. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991; 78: 2918-2922.
14. Komp D, McNamara J, Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic lymphohistiocytosis. Blood 1989; 73: 2128-2132.
15. Hansmann ML et al. Familial hemophagocytic lymphohistiocytosis macrophages showing immunohistochemical properties of activated macrophages and T-accessory cells. Pediatr Hematol Oncol 1989; 6: 237-246.
16. Burgio GR et al. Spontaneous NBT reduction by monocytes as a marker of disease activity in children with histiocytosis. Br J Haematol 1990; 74: 146-150
17. Bujan W et al. Abnormal T-cell phenotype in familial hemophagocytic lymphohistiocytosis. Lancet 1993; 342: 1296.
18. Ambruso DR et al. Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP-16-213. Cancer 1980; 45: 2516-2520.
19. Fischer A et al. Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of epipodophyllotoxin, steroids, intrathecal methotrexate and cranial irradiation. Pediatrics 1985; 76: 263-270.
20. Fischer A et al. Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. J Pediatr 1986; 108: 267-270.
21. Todo S et al. Allogeneic bone marrow transplantation for familial erythrophagocytic lymphohistiocytosis with high dose VP16-containing conditioning regimen. Leuk Lymphoma 1990; 1: 361-364.
22. Blanche S et al. Treatment of hemophagocytic lymphohistiocytosis with chemotherapy and bone marrow transplantation: a single-center cell study of 22 patients. Blood 1991; 78: 51-54.
23. Risdall RJ et al. Virus-associated hemophagocytic syndrome. Cancer 1979; 44: 993-997.
24. Reiner A, Spivak J. Hematophagic histiocytosis. Medicine 1988; 67: 369-388.
25. Henter J-I, Ehrnst A, Andersson J, Elinder G. Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatr 1993; 82: 369-372.
26. Henter J-I, Elinder G, Ost A and the FHI Study Group of the Histiocyte Society. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 1991; 18: 29-33.
27. Himanishi T et al. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T (eds). HLA 1991 Vol.1. Oxford University Press: Oxford, 1992, pp 1065-1220.
28. Kaplan EL, Meier P. Non parametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
29. Marubini E, Valsecchi MG. Analisi della sopravvivenza in sperimentazioni cliniche controllate e nelle osservazioni pianificate. Collana di Monografie del Centro Zambon dell'Università di Milano. 1987; 9: 37-66.
30. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
31. Henter J-I, Elinder G, Lubeck P-O, Ost A. Myelodysplastic syndrome following epipodophyllotoxin therapy in familial hemophagocytic lymphohistiocytosis. Pediatr Haematol Oncol 1993; 10: 163-168.
32. Henter J-I, Elinder G. Cerebromeningeal haemophagocytic lymphohistiocytosis. Lancet 1992; 339: 104-107.
33. Willman CL et al. Langerhan's cell histiocytosis (histiocytosis X) - a clonal proliferative disease. New Engl J Med 1994; 331: 154-160.
34. Willman C. Detection of clonal histiocytes in langerhans cell histiocytosis: biology and clinical significance. Br J Cancer 1994; 70 (suppl): S29-S33.
35. Yu RC, Chu C, Buluwela L, Chu AC. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 1994; 343: 767-768.
36. Stark B et al. Immunologic dysregulation in a patient with familial hemophagocytic lymphohistiocytosis. Cancer 1987; 60: 2629-2636.
37. Kataoka Y et al. Impaired natural killer activity and expression of interleukin-2 receptor antigen in familial erythrophagocytic lymphohistiocytosis. Cancer 1990; 65: 1937-1941.
38. Pui CH et al. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. New Engl J Med 1989; 321: 136-142.
39. Stephan JL et al. Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids and cyclosporin A. Blood 1993; 82: 2319-2323.
40. Loechelt BJ et al. Immunosuppression: preliminary results of alternative maintenance therapy for familial hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 1994; 22: 325-328.
41. Landman-Parker J et al. Partial engraftment of donor bone marrow cells associated with long-term remission of haemophagocytic lymphohistiocytosis. Br J Haematol 1993; 85: 37-41.